USA |NASDAQ |USD
| Report Date | Period Ending | EPS Forecast | Last Quarter's EPS | Last Year's EPS |
|---|---|---|---|---|
| Jul 25, 2022 | Jun 2022 | - | $-0.20 | $-0.20 |
| Report Date | Period Ending | Revenue Forecast | Last Quarter’s Revenue | Last Year’s Revenue |
|---|---|---|---|---|
| Jul 25, 2022 | Jun 2022 | - | - | $1.19M |
Agile Therapeutics, Inc's next earnings date is Monday, Jul 25, 2022 for the fiscal quarter ending Jun 2022.
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2022 | 3 | $-0.39 | $-0.41 | $-0.37 |
| Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
|---|
| Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
|---|---|---|---|---|
| Dec 2022 | 0 / 0 | $-0.39 | $-0.45 | $-0.59 |
| Period End | # of Analysts | Revenue Forecast | Low Revenue Forecast | High Revenue Forecast |
|---|
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2022 | 3 | $19.54M | $15.04M | $25.60M |
| Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
|---|---|---|---|---|
| May 12, 2022 | Mar 2022 | $-4.80 | $-0.20 | 95.87% |
| Mar 30, 2022 | Dec 2021 | $-6.00 | $-8.00 | -33.33% |
| Nov 2, 2021 | Sep 2021 | $-0.19 | $-0.18 | 3.59% |
| Jul 26, 2021 | Jun 2021 | $-0.22 | $-0.20 | 7.41% |
| May 4, 2021 | Mar 2021 | $-0.22 | $-0.20 | 8.05% |
| Mar 1, 2021 | Dec 2020 | $-0.22 | $-0.20 | 10.71% |
| Nov 12, 2020 | Sep 2020 | $-0.18 | $-0.18 | -1.12% |
| Aug 11, 2020 | Jun 2020 | $-0.14 | $-0.12 | 14.29% |
| May 5, 2020 | Mar 2020 | $-0.09 | $-0.10 | -15.34% |
| Feb 20, 2020 | Dec 2019 | $-0.08 | $-0.10 | -33.33% |
| Oct 28, 2019 | Sep 2019 | $-0.08 | $-0.08 | 2.08% |
| Aug 1, 2019 | Jun 2019 | $-0.11 | $-0.08 | 27.27% |
| May 2, 2019 | Mar 2019 | $-0.10 | $-0.13 | -36.84% |
| Mar 12, 2019 | Dec 2018 | $-0.16 | $-0.10 | 34.19% |
| Nov 1, 2018 | Sep 2018 | $-0.15 | $-0.11 | 28.25% |
| Aug 3, 2018 | Jun 2018 | $-0.17 | $-0.14 | 12.85% |
| May 7, 2018 | Mar 2018 | $-0.20 | $-0.21 | -6.06% |
| Mar 12, 2018 | Dec 2017 | $-0.23 | $-0.18 | 21.26% |
| Nov 6, 2017 | Sep 2017 | $-0.25 | $-0.22 | 12.59% |
| Jul 28, 2017 | Jun 2017 | $-0.28 | $-0.26 | 5.80% |
| May 8, 2017 | Mar 2017 | $-0.30 | $-0.26 | 13.33% |
| Mar 8, 2017 | Dec 2016 | $-0.30 | $-0.18 | 40.79% |
| Nov 7, 2016 | Sep 2016 | $-0.34 | $-0.27 | 20.59% |
| Aug 8, 2016 | Jun 2016 | $-0.29 | $-0.29 | 0.58% |
| May 9, 2016 | Mar 2016 | $-0.36 | $-0.27 | 25.68% |
| Mar 9, 2016 | Dec 2015 | $-0.45 | $-0.17 | 62.22% |
| Nov 9, 2015 | Sep 2015 | $-0.42 | $-0.42 | - |
| Aug 13, 2015 | Jun 2015 | $-0.37 | $-0.38 | -2.70% |
| May 12, 2015 | Mar 2015 | $-0.34 | $-0.40 | -17.65% |
| Mar 26, 2015 | Dec 2014 | $-0.43 | $-0.37 | 13.95% |
| Nov 13, 2014 | Sep 2014 | $-0.50 | $-0.34 | 32.00% |
| Aug 14, 2014 | Jun 2014 | $-0.36 | $-0.28 | 22.22% |
| May 28, 2014 | Mar 2014 | - | $0.03 | - |
| Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
|---|---|---|---|---|
| Mar 30, 2022 | Dec 2021 | $-0.73 | $-8.58 | - |
| Mar 1, 2021 | Dec 2020 | $-0.64 | $-0.60 | - |
| Feb 20, 2020 | Dec 2019 | $-0.35 | $-0.39 | - |
| Mar 12, 2019 | Dec 2018 | $-0.62 | $-0.57 | - |
| Mar 12, 2018 | Dec 2017 | $-0.97 | $-0.92 | - |
| Mar 8, 2017 | Dec 2016 | - | $-1.01 | - |
| Mar 9, 2016 | Dec 2015 | - | $-1.37 | - |
| Mar 26, 2015 | Dec 2014 | - | $-0.96 | - |
| Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
|---|---|---|---|---|
| May 12, 2022 | Mar 2022 | $2.30M | - | - |
| Mar 30, 2022 | Dec 2021 | $1.51M | $1.51M | 1.00% |
| Nov 2, 2021 | Sep 2021 | $2.32M | $1.29M | 0.55% |
| Jul 26, 2021 | Jun 2021 | $1.95M | $1.19M | 0.61% |
| May 4, 2021 | Mar 2021 | $160.00K | $116.00K | 0.73% |
| Mar 1, 2021 | Dec 2020 | $1.01M | $749.00K | 0.74% |
| Nov 12, 2020 | Sep 2020 | $0.00 | $0.00 | - |
| Aug 11, 2020 | Jun 2020 | $0.00 | $0.00 | - |
| May 5, 2020 | Mar 2020 | $0.00 | $0.00 | - |
| Feb 20, 2020 | Dec 2019 | $0.00 | $0.00 | - |
| Oct 28, 2019 | Sep 2019 | $0.00 | $0.00 | - |
| Aug 1, 2019 | Jun 2019 | $0.00 | $0.00 | - |
| May 2, 2019 | Mar 2019 | $0.00 | $0.00 | - |
| Mar 12, 2019 | Dec 2018 | $0.00 | $0.00 | - |
| Nov 1, 2018 | Sep 2018 | $0.00 | $0.00 | - |
| Aug 3, 2018 | Jun 2018 | $0.00 | $0.00 | - |
| May 7, 2018 | Mar 2018 | $0.00 | $0.00 | - |
| Mar 12, 2018 | Dec 2017 | $0.00 | $0.00 | - |
| Nov 6, 2017 | Sep 2017 | - | $0.00 | - |
| Jul 28, 2017 | Jun 2017 | - | $0.00 | - |
| May 8, 2017 | Mar 2017 | - | $0.00 | - |
| Mar 8, 2017 | Dec 2016 | - | $0.00 | - |
| Nov 7, 2016 | Sep 2016 | - | $0.00 | - |
| Aug 8, 2016 | Jun 2016 | - | $0.00 | - |
| May 9, 2016 | Mar 2016 | - | $0.00 | - |
| Mar 9, 2016 | Dec 2015 | - | $0.00 | - |
| Nov 9, 2015 | Sep 2015 | - | $0.00 | - |
| Aug 13, 2015 | Jun 2015 | - | $0.00 | - |
| May 12, 2015 | Mar 2015 | - | $0.00 | - |
| Mar 26, 2015 | Dec 2014 | - | $0.00 | - |
| Nov 13, 2014 | Sep 2014 | - | $0.00 | - |
| Aug 14, 2014 | Jun 2014 | - | $0.00 | - |
| May 28, 2014 | Mar 2014 | - | $0.00 | - |
| Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
|---|---|---|---|---|
| Mar 30, 2022 | Dec 2021 | $4.10M | $4.10M | 0.02% |
| Mar 1, 2021 | Dec 2020 | $1.01M | $749.00K | -25.84% |
| Feb 20, 2020 | Dec 2019 | $0.00 | $0.00 | - |
| Mar 12, 2019 | Dec 2018 | $0.00 | $0.00 | - |
| Mar 12, 2018 | Dec 2017 | $0.00 | $0.00 | - |
| Mar 8, 2017 | Dec 2016 | - | $0.00 | - |
| Mar 9, 2016 | Dec 2015 | - | $0.00 | - |
| Mar 26, 2015 | Dec 2014 | - | $0.00 | - |
AGRX's next earnings date is Monday, Jul 25, 2022 for the fiscal quarter ending Jun 30, 2022.
Agile Therapeutics, Inc's previous earnings date was May 12, 2022 for its fiscal quarter ended Mar 31, 2022.
AGRX's earnings per share (EPS) was $-0.20, beating the consensus analysts forecast of $-4.80 by 95.87%.
The EPS was higher than the previous fiscal quarter (Dec 2021) by -97.52%, and higher than the same period a year before (Mar 2021) by -0.95%.
Agile Therapeutics, Inc's previous annual earnings date was Mar 30, 2022 for its fiscal year ended Dec 31, 2021.
AGRX's earnings per share (EPS) was $-8.58, missing the consensus analysts forecast of $-0.73 by 1075.34% , and lower than the previous year's EPS (Dec 2020) by 1330.00%.
Revenues were $4.10M, better than the forecast of $4.10M by 0.02%, and up by 447.53% from previous year's revenue.
The company reported a net income of $-74.89M.
Agile Therapeutics, Inc reported a free cash flow of $-65.47M for its fiscal year, compared to $-47.66M a year ago.
The company ended the fiscal year with $17.79M in total debt, an increase of 7.71% compared to the previous year.
Get a weekly snapshot of one new investment idea from stock exchanges worldwide.
